{
    "ticker": "NMT",
    "name": "NeuroMetrix, Inc.",
    "description": "NeuroMetrix, Inc. is a healthcare technology company focused on the development and commercialization of innovative products for the management of chronic pain and the treatment of neurological disorders. Founded in 1996, NeuroMetrix is recognized for its pioneering work in neurostimulation and biometrics. The company's flagship product, Quell, is an FDA-cleared wearable device that uses neurostimulation to provide relief for chronic pain without the need for drugs. This non-invasive technology represents a significant advancement in pain management, allowing patients to manage their conditions effectively and improve their quality of life. In addition to Quell, NeuroMetrix is advancing its research and development pipeline, focusing on both consumer and clinical applications, including diabetic neuropathy and neurodegenerative diseases. The company's mission is to harness the power of neurotechnology to transform the way chronic pain and neurological conditions are treated, thereby enhancing patient outcomes and reducing healthcare costs. With a commitment to innovation and a strong intellectual property portfolio, NeuroMetrix is well-positioned in the burgeoning field of digital health and neurotherapeutics.",
    "industry": [
        "Healthcare",
        "Medical Devices"
    ],
    "headquarters": "Woburn, Massachusetts, USA",
    "founded": "1996",
    "website": "https://www.neurometrix.com",
    "ceo": "Shai Gozani",
    "social_media": {
        "twitter": "https://twitter.com/NeuroMetrix",
        "linkedin": "https://www.linkedin.com/company/neurometrix"
    },
    "investor_relations": "https://www.neurometrix.com/investors",
    "key_executives": [
        {
            "name": "Shai Gozani",
            "position": "CEO"
        },
        {
            "name": "Cynthia A. Koenig",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Pain Management",
            "products": [
                "Quell"
            ]
        },
        {
            "category": "Neuromodulation Devices",
            "products": [
                "DPNCheck"
            ]
        }
    ],
    "seo": {
        "meta_title": "NeuroMetrix, Inc. | Innovative Neurotechnology for Pain Management",
        "meta_description": "Discover NeuroMetrix, Inc., a leader in healthcare technology focused on neurostimulation and chronic pain management. Explore our innovative products and commitment to improving patient outcomes.",
        "keywords": [
            "NeuroMetrix",
            "Chronic Pain",
            "Neurostimulation",
            "Healthcare Technology",
            "Wearable Devices"
        ]
    },
    "faq": [
        {
            "question": "What is NeuroMetrix known for?",
            "answer": "NeuroMetrix is known for its innovative wearable devices for chronic pain management, particularly the Quell device."
        },
        {
            "question": "Who is the CEO of NeuroMetrix?",
            "answer": "Shai Gozani is the CEO of NeuroMetrix, Inc."
        },
        {
            "question": "Where is NeuroMetrix headquartered?",
            "answer": "NeuroMetrix is headquartered in Woburn, Massachusetts, USA."
        },
        {
            "question": "What are NeuroMetrix's main products?",
            "answer": "NeuroMetrix's main products include Quell for pain management and DPNCheck for diabetic neuropathy assessment."
        },
        {
            "question": "When was NeuroMetrix founded?",
            "answer": "NeuroMetrix was founded in 1996."
        }
    ],
    "competitors": [
        "AXGN",
        "STIM",
        "NVRO"
    ],
    "related_stocks": [
        "AAPL",
        "MSFT",
        "AMGN",
        "JNJ"
    ]
}